← Back to headlines

Zoetis Stock Rises on FDA EUA for Simparica TRIO
Zoetis shares increased after the FDA granted Emergency Use Authorization (EUA) for its Simparica TRIO drug to treat New World screwworm.
13 Aug, 17:23 — 13 Aug, 17:23
Sources
Showing 1 of 1 sources


